BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9082059)

  • 1. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors.
    MacFadyen RJ; Lees KR; Reid JL
    J Hypertens Suppl; 1991 Dec; 9(6):S376-7. PubMed ID: 1818999
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of captopril on serum angiotensin converting enzyme and blood pressure in hypertensive patients.
    Singh R; Kalra OP; Sarma PU; Prabhu KM
    J Assoc Physicians India; 1996 Feb; 44(2):109-11. PubMed ID: 10999062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preventive chronotherapy with capoten in hypertensive outpatients].
    Zaslavskaia RM; Iskakova MT; Teĭblium MM
    Klin Med (Mosk); 1999; 77(3):39-41. PubMed ID: 10234946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin-converting enzyme inhibition: a pathophysiologically based concept for the therapy of hypertension and heart failure].
    Stumpe KO; Overlack A; Kolloch R
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1295-9. PubMed ID: 6088205
    [No Abstract]   [Full Text] [Related]  

  • 9. [When must, when should, when can ACE inhibitors be administered in heart failure?].
    Jahrmärker H
    Med Klin (Munich); 1993 Aug; 88(8):496-502. PubMed ID: 8413052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
    Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS
    Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictability of a standardized captopril-test in hypertension in end-stage renal failure.
    Schohn DC; Jahn HA; Schmitt RL
    Kidney Int Suppl; 1988 Sep; 25():S145-8. PubMed ID: 3054231
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of captopril (tensiomin) in the long-term treatment of arterial hypertension].
    Kakaliia E; Belousov IuB; Bykov AV; Sidorskiĭ AL
    Sov Med; 1991; (10):45-8. PubMed ID: 1801235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does captopril decrease endothelial production of endothelin?].
    Mazurek W; Halawa B
    Pol Merkur Lekarski; 1997 Sep; 3(15):105-8. PubMed ID: 9461703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Captopril in the treatment of mild cardiac insufficiency in combination with arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Ter Arkh; 1987; 59(4):103-6. PubMed ID: 3296282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
    Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
    Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
    Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
    Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.